Amlodipine and Carvedilol Prevent Cytotoxicity in Cortical Neurons Isolated from Stroke-Prone Spontaneously Hypertensive Rats

1. Yamori Y, Nagaoka A, Okamoto K: Importance of genetic factors in hypertensive cerebrovascular lesions: an evidence obtained by successive selective breeding of stroke-prone and -resistant SHR. <I>Jpn Circ J</I> 1974; <B>38</B>: 1095-1100.

2. Gemba T, Ninomiya M, Matsunaga K, Ueda M: Changes in extracellular concentration of amino acids in the hippocampus during cerebral ischemia in stroke-prone SHR, stroke-resistant SHR and normotensive rats. <I>Neurosci Lett</I> 1992; <B>135</B>: 184-188.

3. Tagami M, Yamagata K, Ikeda K, <I>et al</I>: Vitamin E prevents apoptosis in cortical neurons during hypoxia and oxygen reperfusion. <I>Lab Invest</I> 1998; <B>78</B>: 1415-1429.

4. Tagami M, Ikeda K, Yamagata K, <I>et al</I>: Vitamin E prevents apoptosis in hipocampal neurons caused by cerebral ischemia and reperfusion in stroke-prone spontaneously hypertensive rat. <I>Lab Invest</I> 1999; <B>79</B>: 609-615.

5. Noguchi T, Ikeda K, Sasaki Y, <I>et al</I>: Effects of vitamin E and sesamin on hypertension and cerebral thrombogenesis in stroke-prone spontaneously hypertensive rats. <I>Hypertens Res</I> 2001; <B>24</B>: 735-742.

6. Negishi H, Ikeda K, Nara Y, Yamori Y: Increased hydroxyl radicals in the hippocampus of stroke-prone spontaneously hypertensive rats during transient ischemia and recirculation. <I>Neurosci Lett</I> 2001; <B>306</B>: 206-208.

7. Horakova L, Stolc S, Chromikova Z, Pekarova A, Derkova L: Mechanisms of hippocampal reoxygenation injury: treatment with antioxidants. <I>Neuropharmacology</I> 1997; <B>36</B>: 177-184.

8. McIntosh LJ, Trush MA, Troncoso JC: Increased susceptibility of Alzheimer&rsquo;s disease temporal cortex to oxygen free radical-mediated processes. <I>Free Radic Biol Med</I> 1997; <B>23</B>: 183-190.

9. Orekhov AN, Tertov VV, Pivovarova EM: The effects of antihypertensive agents on atherosclerosis-related parameters of human aorta intimal cells. <I>Cardiology</I> 1998; <B>89</B>: 111-118.

10. Lai YM, Fukuda N, Su JZ, <I>et al</I>: Novel mechanisms of the antiproliferative effects of amlodipine in vascular smooth muscle cells from spontaneously hypertensive rats. <I>Hypertens Res</I> 2002; <B>25</B>: 109-115.

11. Chen L, Haught WH, Yang B, Saldeen TG, Parathasarathy S, Mehta JL: Preservation of endogenous antioxidant activity and inhibition of lipid peroxidation as common mechanisms of antiatherosclerotic effects of vitamin E, lovastatin and amlodipine. <I>J Am Coll Cardiol</I> 1997; <B>30</B>: 569-575.

12. Ma XL, Lopez BL, Liu GL, <I>et al</I>: Hypercholesterolemia impairs a detoxification mechanism against peroxynitrite and renders the vascular tissue more susceptible to oxidative injury. <I>Circ Res</I> 1997; <B>80</B>: 894-901.

13. Douglas SA, Vickery-Clark LM, Louden C, Ruffolo RR: Feuerstein GZ, Ohlstein EH: Acute pretreatment with carvedilol is sufficient for inhibition of neointima formation following rat carotid artery balloon angioplasty. <I>Pharmacol Res Commun</I> 1994; <B>5</B>: 65-72.

14. Ohlstein EH, Douglas SA, Sung CP, <I>et al</I>: Carvedilol, a novel cardiovascular drug, prevents vascular smooth muscle cell proliferation, migration, and neointimal formation following vascular injury. <I>Proc Natl Acad Sci U S A</I> 1993; <B>90</B>: 6189-6193.

15. Sung CP, Arleth AJ, Ohlstein EH: Carvedilol inhibits vascular smooth muscle cell proliferation. <I>J Cardiovasc Pharmacol</I> 1993; <B>21</B>: 221-227.

16. Kusmic C, Picano E, Busceti CL, Petersen C, Barsacchi R: The antioxidant drug dipyridamole spares the vitamin E and thiols in red blood cells after oxidative stress. <I>Cardiovasc Res</I> 2000; <B>47</B>: 510-514.

17. Inouye M, Mio T, Sumino K: Nilvadipine protects low-density lipoprotein cholesterol from <I>in vivo</I> oxidation in hypertensive patients with risk factors for atherosclerosis. <I>Eur J Clin Pharmacol</I> 2000; <B>56</B>: 35-41.

18. Tagami M, Yamagata K, Nara Y, <I>et al</I>: Insulin-like growth factors prevent apoptosis in cortical neurons isolated from stroke-prone spontaneously hypertensive rats. <I>Lab Invest</I> 1997; <B>76</B>: 603-612.

19. Hewett SJ, Csernasky CA, Choi DW: Selective potentiation of NMDA-induced neuronal injury following induction of astrocytic iNOS. <I>Neuron</I> 1994; <B>13</B>: 487-494.

20. Bieri JG, Corash L, Hubbard VS: Medical uses of vitamin E. <I>N Engl J Med</I> 1983; <B>308</B>: 1063-1071.

21. Kukreja RC, Hess ML: The oxygen free radical system: from equations through membrane-protein interactions to cardiovascular injury and protection. <I>Cardiovasc Res</I> 1992; <B>26</B>: 641-655.

22. Gonzalez-Polo RA, Soler G, Alvarez A, Fabregat I, Fuentes JM: Vitamin E blocks early events induced by 1-methyl-4-phenylpyridinium (MPP+) in cerebellar granule cells. <I>J Neurochem</I> 2003; <B>84</B>: 305-315.

23. Mason RP, Leeds PR, Jacob RF, <I>et al</I>: Inhibition of excessive neuronal apoptosis by the calcium antagonist amlodipine and antioxidants in cerebellar granule cells. <I>J Neurochem</I> 1999; <B>72</B>: 1448-1456.

24. Abernethy DR: Parmacokinetics and pharmacodynamics of amlodipine. <I>Cardiology</I> 1992; <B>80</B> (Suppl 1): 31-36.

25. Tomiyama H, Kimura Y, Kuwabara Y, <I>et al</I>: Cilnidipine more highly attenuates cold pressor stress-induced platelet activation in hypertension than does amlodipine. <I>Hypertens Res</I> 2001; <B>24</B>: 679-684.

26. Munoro E, Patel M, Chan P, <I>et al</I>: Effect of calcium channel blokers on the growth of human vascular smooth muscle cells derived from saphenous vein and vascular graft stenoses. <I>J Cardiovasc Pharmacol</I> 1994; <B>23</B>: 779-784.

27. Chen L, Haught WH, Yang B, <I>et al</I>: Preservation of endogenous antioxidant activity and inhibition of lipid peroxidation as common mechanisms of antiatherosclerotic effects of vitamin E, lovastatin and amlodipine. <I>J Am Coll Cardiol</I> 1997; <B>30</B>: 569-575.

28. Ito H, Torii M, Suzuki T: Decreased superoxide dismutase activity and increased superoxide anion production in cardiac hypertrophy of spontaneously hypertensive rats. <I>Clin Exp Hypertens</I> 1995; <B>17</B>: 803-816.

29. Mason RP, Walter MF, Trumbore MW, Olmstead EG Jr, Mason PE: Membrane antioxidant effects of the charged dihydropyridine calcium antagonist amlodipine. <I>J Mol Cell Cardiol</I> 1999; <B>31</B>: 275-281.

30. Yue TL, Cheng HY, Lysko PG, McKenna PJ, Feuerstein GZ: Carvedilol, a new vasodilator and beta-adrenoceptor antagonist, is an antioxidant and free radical scavenger. <I>J Pharmacol Exp Ther</I> 1992; <B>263</B>: 92-98.

31. Yue T-L, McKenna PJ, Lysko PG, <I>et al</I>: A metabolite of carvedilol, a novel antihypertensive agent, is a potent antioxidant. <I>Eur J Pharmacol</I> 1994; <B>251</B>: 237-243.

32. Lysko PG, Lysko KA, Yue TL, Webb CL, Gu JL, Feuerstein G: Neuroprotective effects of carvedilol, a new antihypertensive agent, in cultured rat cerebellar neurons and in gerbil global brain ischemia. <I>Stroke</I> 1992; <B>23</B>: 1630-1635.

33. Iuliano L, Viol F, Ghiselli A, Alessandri C, Balsono F: Dipyridamole inhibits lipid peroxidation and scavenges oxygen radicals. <I>Lipid</I> 1989; <B>24</B>: 430-433.

34. Iuliano L, Pedersen JZ, Rotillio G, Violi F: A potent chain-breaking antioxidant activity of the cardiovascular drug dipyridamole. <I>Free Radic Biol Med</I> 1995; <B>18</B>: 239-247.

35. Farinelli SE, Green LA, Friedman WJ: Neuroprotective actions of dipyridamole on cultured CNS neurons. <I>J Neurosci</I> 1998; <B>18</B>: 5112-5123.

36. Tagami M, Yamagata K, Ikeda K, <I>et al</I>: Genetic vulnerability of cortical neurons isolated from stroke-prone spontaneously hypertensive rats in hypoxia and oxygen reperfusion. <I>Hypertens Res</I> 1999; <B>22</B>: 23-29.

37. Kawamura S, Shirasawa M, Fukasawa H, Yasui N: Attenuated neuropathology by nilvadipine after middle cerebral artery occlusion in rats. <I>Stroke</I> 1991; <B>22</B>: 41-55.

38. Tanaka S, Furuichi Y, Satoh H, Mori J, Kohsaka M: Effects on nilvadipine on neuronal function in the ischemic cat brain. <I>Surg Neuronal</I> 1992; <B>37</B>: 255-260.

39. Ishibashi H, Rhee JS, Akaike N: Effect of nilvadipine on high-voltage activated Ca<SUP>2+</SUP> channels in rat CSN neurons. <I>Neuroreport</I> 1997; <B>8</B>: 853-857.

40. Halliwell B: Reactive oxygen species and the central nervous system. <I>J Neurochem</I> 1992; <B>59</B>: 1609-1623.

41. Gerlach M, Ben-Shachar D, Riederer P, Youdim MBH: Altered brain metabolism of iron as a cause of neurodegenerative diseases? <I>J Neurochem</I> 1994; <B>63</B>: 793-807.

42. Sano M, Ernesto C, Thomas RG, <I>et al</I>: A controlled trial of selegiline, alpha-tocopfenol, or both as treatment for Alzheimer&rsquo;s disease. <I>N Engl J Med</I> 1997; <B>336</B>: 1216-1222.